Literature DB >> 17548789

Advances in the use of milk thistle (Silybum marianum).

Janice Post-White1, Elena J Ladas, Kara M Kelly.   

Abstract

Milk thistle (Silybum marianum) is an herbal supplement used to treat liver and biliary disorders. Silymarin, a mixture of flavanoid complexes, is the active component that protects liver and kidney cells from toxic effects of drugs, including chemotherapy. Although milk thistle has not significantly altered the course of chronic liver disease, it has reduced liver enzyme levels and demonstrated anti-inflammatory and T cell-modulating effects. There is strong preclinical evidence for silymarin's hepatoprotective and anticarcinogenic effects, including inhibition of cancer cell growth in human prostate, skin, breast, and cervical cells. Milk thistle is considered safe and well-tolerated, with gastrointestinal upset, a mild laxative effect, and rare allergic reaction being the only adverse events reported when taken within the recommended dose range. More clinical trials of rigorous methodology, using standardized and well-defined products and dosages, are needed to evaluate the potential of silymarin against liver toxicity, chronic liver disease, and human cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548789     DOI: 10.1177/1534735407301632

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  36 in total

1.  Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.

Authors:  Eun-Sun Choi; Sejun Oh; Boonsil Jang; Hyun-Ju Yu; Ji-Ae Shin; Nam-Pyo Cho; In-Hyoung Yang; Dong-Hoon Won; Hye-Jeong Kwon; Seong Doo Hong; Sung-Dae Cho
Journal:  Cell Oncol (Dordr)       Date:  2017-04-11       Impact factor: 6.730

2.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

3.  In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin.

Authors:  Ebru Evren; Erkan Yurtcu
Journal:  Folia Microbiol (Praha)       Date:  2015-05-04       Impact factor: 2.099

4.  Molecular insights of genetic variation in milk thistle (Silybum marianum [L.] Gaertn.) populations collected from southwest Iran.

Authors:  Azam Rafizadeh; Mehrana Koohi-Dehkordi; Karim Sorkheh
Journal:  Mol Biol Rep       Date:  2018-06-07       Impact factor: 2.316

5.  Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride.

Authors:  Nouf M Al-Rasheed; Nawal M Al-Rasheed; L M Faddah; Azza M Mohamed; Raeesa A Mohammad; Maha Al-Amin
Journal:  Saudi J Biol Sci       Date:  2013-09-17       Impact factor: 4.219

6.  The protective effect of silymarin on the carbon tetrachloride (CCl4)-induced liver injury in common carp (Cyprinus carpio).

Authors:  Rui Jia; Liping Cao; Jinliang Du; Pao Xu; Galina Jeney; Guojun Yin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-22       Impact factor: 2.416

7.  Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.

Authors:  Subapriya Rajamanickam; Balaiya Velmurugan; Manjinder Kaur; Rana P Singh; Rajesh Agarwal
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

8.  Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.

Authors:  Scott J Brantley; Nicholas H Oberlies; David J Kroll; Mary F Paine
Journal:  J Pharmacol Exp Ther       Date:  2009-11-24       Impact factor: 4.030

Review 9.  Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer.

Authors:  Samiha Mateen; Komal Raina; Rajesh Agarwal
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

10.  Silymarin secretion and its elicitation by methyl jasmonate in cell cultures of Silybum marianum is mediated by phospholipase D-phosphatidic acid.

Authors:  Elena Madrid; Purificación Corchete
Journal:  J Exp Bot       Date:  2009-12-09       Impact factor: 6.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.